Novel Topical Microemulsion Formulations for The Treatment of Rheumetic Disorders and Related Infec

Home » Technology » New Technologies » DST-Lockheed Martin India Innovation » Novel Topical Microemulsion Formulations for The Treatment of Rheumetic Disorders and Related Infec

Technology Description

This technology is nanoparticle based topical microemulsion formulation for the treatment of rheumatic disorders and related infections.

  • The technology is nanotechnology based and has been designed for quicker relief from Rheumatic pain. The nano particles in the formulation will enable faster penetration of the medicine inside the body and thus faster onset of action.
  • The primary purpose of the technology is to provide treatment for different types of arthritis including osteoarthritis, gouty arthritis, rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriatic arthritis, sprains and backache.
  • The target for this technology is people suffering from such disorders and any other related infections.
  • The technology has potential to be accepted in to the pharmaceutical industry, hospitals and the health care industry.
  • As claimed by the innovator, this is a stand-alone formulation, but can be integrated with other medicines as it is a topical microemulsion.
  • Being herbal based, the technology has no added artificial preservatives, no side effects, and is skin friendly. Also, it's characteristics include no stain, non-sticky, non-irritant, and non-toxic.

For further information please contact

Information Manager
Email: timeis@ficci.com